Strattera (Atomoxetine) Dosing in Patients on Buspar, Lexapro, and Trazodone
Start atomoxetine at 40 mg daily and increase to a target dose of 80 mg daily after a minimum of 3 days, but only increase to 80 mg after 4 weeks if symptoms fail to improve and the initial dose is well tolerated, because escitalopram (Lexapro) is a strong CYP2D6 inhibitor that significantly increases atomoxetine levels. 1
Initial Dosing Strategy
- Begin with 40 mg once daily (either morning or split between morning and late afternoon/early evening) 1
- Wait a minimum of 3 days before any dose adjustment 1
- The usual target dose would be 80 mg daily, but this requires careful titration due to the drug interaction 1
Critical Drug Interaction: Escitalopram (Lexapro)
- Escitalopram inhibits CYP2D6, the primary enzyme metabolizing atomoxetine 1
- When atomoxetine is combined with strong CYP2D6 inhibitors like escitalopram, initial doses should be maintained at 40 mg/day 1
- Only increase to 80 mg after 4 weeks if symptoms fail to improve AND the initial 40 mg dose is well tolerated 1
- This conservative approach prevents excessive atomoxetine accumulation and reduces risk of adverse effects 1
Maximum Dosing Parameters
- The maximum recommended total daily dose is 100 mg for adults 1
- However, given the CYP2D6 inhibition from escitalopram, reaching maximum doses should be approached cautiously 1
- Doses above 80 mg should only be considered after 2-4 additional weeks if optimal response has not been achieved 1
Additional Considerations with Concurrent Medications
Buspirone (Buspar)
- No significant pharmacokinetic interaction with atomoxetine 2
- One study showed atomoxetine plus buspirone was well-tolerated with discontinuation rates of 15.5% due to adverse effects 2
- Common side effects when combined include insomnia, nausea, dry mouth, headache, and dizziness 2
Trazodone
- No direct pharmacokinetic interaction with atomoxetine reported in the evidence
- Trazodone is commonly used for sleep at doses of 25-400 mg daily 3
- Both medications can cause sedation, so monitor for additive CNS effects 4
Serotonin Syndrome Risk
- Monitor carefully for serotonin syndrome when combining multiple serotonergic agents (escitalopram, trazodone, and potentially buspirone) 5
- Watch for diaphoresis, tremor, diarrhea, mydriasis, and mental status changes 5
- While atomoxetine primarily affects norepinephrine, the combination of escitalopram and trazodone already increases serotonin syndrome risk 5
Practical Dosing Algorithm
- Week 1-4: Atomoxetine 40 mg daily (single morning dose or divided doses)
- Week 4 assessment: If inadequate response AND good tolerability → increase to 80 mg daily
- Week 6-8 assessment: If still inadequate response AND good tolerability → may increase to 100 mg daily maximum
- Maintenance: Continue effective dose; can be discontinued without tapering 1
Monitoring Requirements
- Assess ADHD symptoms using standardized rating scales at each dose adjustment 1
- Monitor blood pressure and heart rate as atomoxetine can increase both 1
- Screen for mood changes, particularly increased anxiety or agitation, given the activating nature of atomoxetine 2
- Watch for serotonergic symptoms given the polypharmacy with multiple serotonergic agents 5
- Evaluate sleep patterns as the combination may affect sedation levels differently than individual agents 4
Common Pitfalls to Avoid
- Do not use standard adult dosing (rapid escalation to 80 mg after 3 days) due to the CYP2D6 inhibition from escitalopram 1
- Do not open atomoxetine capsules; they must be swallowed whole 1
- Do not exceed 100 mg total daily dose regardless of response 1
- Do not ignore the 4-week waiting period before increasing from 40 mg to 80 mg when on CYP2D6 inhibitors 1